ZFIN ID: ZDB-FISH-161117-16
Fish name: sf3b1hi3394aTg/hi3394aTg
Genotype: sf3b1hi3394aTg/hi3394aTg
Targeting Reagent: none
HUMAN DISEASE MODELED by sf3b1hi3394aTg/hi3394aTg
No data available
GENE EXPRESSION
Gene expression in sf3b1hi3394aTg/hi3394aTg
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in sf3b1hi3394aTg/hi3394aTg
Phenotype Conditions Figures
aorta development process quality, normal standard conditions Fig. 5 from De La Garza et al., 2016
arterial endothelial cell fate commitment process quality, normal standard conditions Fig. 5 from De La Garza et al., 2016
blood island myeloid cell spi1b expression decreased amount, abnormal standard conditions Fig. 3 from De La Garza et al., 2016
erythroblast increased amount, abnormal standard conditions Fig. 1 from De La Garza et al., 2016
hematopoietic cell apoptotic process process quality, normal standard conditions Fig. SE4 from De La Garza et al., 2016
myeloid cell spi1b expression decreased amount, abnormal standard conditions Fig. 2 from De La Garza et al., 2016
myeloid cell mpx expression decreased amount, abnormal standard conditions Fig. 2Fig. 3 from De La Garza et al., 2016
myeloid cell lcp1 expression decreased amount, abnormal standard conditions Fig. 2Fig. 3 from De La Garza et al., 2016
myeloid cell differentiation disrupted, abnormal standard conditions Fig. 3 from De La Garza et al., 2016
nucleate erythrocyte decreased amount, abnormal standard conditions Fig. 1Fig. 5 from De La Garza et al., 2019
Fig. 1 from De La Garza et al., 2016
nucleate erythrocyte hbbe3 expression decreased amount, abnormal control Fig. 1 from De La Garza et al., 2019
nucleate erythrocyte decreased amount, exacerbated chemical treatment by environment: SB 431542 Fig. 5 from De La Garza et al., 2019
nucleate erythrocyte increased amount, abnormal control Fig. 1 from De La Garza et al., 2019
nucleate erythrocyte hbbe3 expression increased amount, abnormal control Fig. 1Fig. S1 from De La Garza et al., 2019
nucleate erythrocyte differentiation disrupted, abnormal standard conditions Fig. 1 from De La Garza et al., 2016
primitive hemopoiesis process quality, normal standard conditions Fig. 1 from De La Garza et al., 2016
ventral wall of dorsal aorta hematopoietic stem cell gata2b expression decreased amount, abnormal standard conditions Fig. 4 from De La Garza et al., 2016
ventral wall of dorsal aorta hematopoietic stem cell runx1 expression decreased amount, abnormal standard conditions Fig. 4 from De La Garza et al., 2016

CITATIONS  (2)